Chemistry and biology of the ELISPOT assay.

Enzyme-linked immunospot, or ELISPOT, assay allows the detection of low frequencies of cells secreting various molecules. ELISPOT can be used in many areas of research and, because of its high sensitivity, has the potential to become a valuable diagnostic tool. Based on the same "sandwich" immunochemical principles as enzyme-linked immunosorbent assay, ELISPOT is easy to perform and quantify the results. At the same time ELISPOT remains a state-of-the-art technique that requires accuracy, thorough selection of antibodies and detection reagents, and an understanding of the principles of data analysis. This review covers various technical aspects of the ELISPOT assay, including immunochemical principles of the assay, selection of reagents and plates, and troubleshooting recommendations.

[1]  J. Palefsky,et al.  Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  H. Ayles,et al.  Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells , 2002, AIDS.

[3]  C. Bizer,et al.  Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases1 , 2002, The Journal of Immunology.

[4]  J. Bienvenu,et al.  The Clinical Usefulness of the Measurement of Cytokines , 2000, Clinical chemistry and laboratory medicine.

[5]  N. Leister,et al.  The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. , 1997, Journal of immunological methods.

[6]  L. Hsiao,et al.  A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. , 1997, Journal of immunological methods.

[7]  C. Gray,et al.  The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes , 2002, Clinical chemistry and laboratory medicine.

[8]  C. Czerkinsky,et al.  Amplified ELISPOT assay for the detection of HIV-specific antibody-secreting cells in subhuman primates. , 1992, Journal of immunological methods.

[9]  L. Klareskog,et al.  A comparison between ELISPOT methods for the detection of cytokine producing cells: greater sensitivity and specificity using ELISA plates as compared to nitrocellulose membranes. , 1997, Journal of immunological methods.

[10]  Malin,et al.  Human CD 8 1 CTL Specific for the Mycobacterial Major Secreted Antigen 85 A 1 , 2000 .

[11]  J. Tekstra,et al.  Quantification of natural antibody producing B cells in rats by an improved ELISPOT technique using the polyvinylidene difluoride membrane as the solid support. , 1995, Journal of immunological methods.

[12]  O Ouchterlony,et al.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. , 1983, Journal of immunological methods.

[13]  Y. Okamoto,et al.  Development of a dual color enzyme-linked immunospot assay for simultaneous detection of murine T helper type 1- and T helper type 2-cells. , 1998, Immunopharmacology.

[14]  Y. Gotoh,et al.  Characterization of the cytokine network at a single cell level in mice with collagen-induced arthritis using a dual color ELISPOT assay. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  S. Stark,et al.  A simple method to reduce the background and improve well-to-well reproducibility of staining in ELISPOT assays. , 2001, Journal of immunological methods.

[16]  C. Czerkinsky,et al.  A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. , 1988, Journal of immunological methods.

[17]  Gerald C. Holst,et al.  CCD arrays, cameras, and displays , 1996 .

[18]  Jonathan J. Lewis,et al.  Insect cells as HLA-restricted antigen-presenting cells for the IFN-γ Elispot assay , 2000 .

[19]  S. Steinberg,et al.  The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines , 2000, Cancer Immunology, Immunotherapy.

[20]  M. Sayegh,et al.  New Insights Into the Interactions Between T-Cell Costimulatory Blockade and Conventional Immunosuppressive Drugs , 2002, Annals of surgery.

[21]  E. Thiel,et al.  Quantification of Tumor-Specific T Lymphocytes With the ELISPOT Assay , 2000, Journal of immunotherapy.

[22]  P. Martiat,et al.  Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuli. , 2000, Journal of immunological methods.

[23]  D. Baxby.  Recombinant poxvirus vaccines , 1993 .

[24]  T. Whiteside,et al.  Evaluation of the Modified ELISPOT Assay for Gamma Interferon Production in Cancer Patients Receiving Antitumor Vaccines , 2000, Clinical Diagnostic Laboratory Immunology.

[25]  T. Ogawa,et al.  Cellular analysis of functional mononuclear cells from chronically inflamed gingival tissue. , 1989, Regional immunology.

[26]  R. Hunter,et al.  Use of cryopreserved cells in quality control of human lymphocyte assays: analysis of variation and limits of reproducibility in long-term replicate studies. , 1979, Clinical and experimental immunology.

[27]  R. Rudick,et al.  Sex differences in cytokine responses to myelin peptides in multiple sclerosis , 2002, Journal of Neuroimmunology.

[28]  R. Coffman,et al.  Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. , 1990, Journal of immunological methods.

[29]  A. Bean,et al.  Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon‐gamma (IFN‐γ)‐secreting lymphocytes , 2000, Clinical and experimental immunology.

[30]  A. Lohse,et al.  Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. , 1996, Journal of immunological methods.

[31]  G. Bordmann,et al.  Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR. , 1997, Journal of immunological methods.

[32]  Adrian V. S. Hill,et al.  Human CD8+ CTL Specific for the Mycobacterial Major Secreted Antigen 85A1 , 2000, The Journal of Immunology.

[33]  P. Fitzgerald-Bocarsly,et al.  Decreased frequency of functional natural interferon-producing cells in peripheral blood of patients with the acquired immune deficiency syndrome. , 1994, Clinical immunology and immunopathology.

[34]  M. Venkataraman.  Effects of Cryopreservation on Immune Responses , 1995 .

[35]  M. John,et al.  Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy. , 2000, AIDS research and human retroviruses.

[36]  P. Holt,et al.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. , 1983, Journal of immunological methods.

[37]  J. Bubeník,et al.  Use of cryopreserved lymphocytes for assessment of the immunological effects of interferon therapy in renal cell carcinoma patients. , 1997, Journal of immunological methods.

[38]  J. Killion,et al.  Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. , 1994, Lymphokine and cytokine research.

[39]  Xu Liu,et al.  Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster Virus , 2001, Clinical Diagnostic Laboratory Immunology.

[40]  J. Banchereau,et al.  DETECTION OF SINGLE CELLS SECRETING IFN‐GAMMA, IL‐6, AND IL‐10 IN IRREVERSIBLY REJECTED HUMAN KIDNEY ALLOGRAFTS, AND THEIR MODULATION BY IL‐2 AND IL‐4 , 1993, Transplantation.

[41]  A. Scheynius,et al.  Cytokine production in nickel‐sensitized individuals analysed with enzyme‐linked immunospot assay: possible implication for diagnosis , 2002, The British journal of dermatology.

[42]  S. Rosenberg,et al.  Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay. , 1998, The cancer journal from Scientific American.